Skip to content
FIND A BIOALPS ACTOR

Actor

Gene Signal International SA

Share this actor

Development of innovative therapies for angiogenesis disorders based on a new class of oligonucleotides, proteins and monoclonal antibodies derived from genes exclusively involved in the angiogenesis process.

Specialties

Primary Therapeutic Areas

Gene Therapy

Therapeutics & Diagnostics

Business model

R&D

Organization Type

Headquarters

Private Company


Visit website

Domains

Dermatology, Ophtalomology, Other

Contact

EPFL Innovation Park Bat A
1015 Lausanne / VD
021 804 61 64